Form 4 for OMDA Omada Health, Inc.
Accepted 2026-08-12 16:48:44 ET · period of report 2026-08-10 · accession 0001610717-26-000356 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-12 16:48 | 2026-08-10+ | OMDA | Cook Steven L. | CFO | M - OptEx | $8.24 | +16.8K | 188.8K | +10% | +$138.8K |
| DMT | 2026-08-12 16:48 | 2026-08-10+ | OMDA | Cook Steven L. | CFO | S - Sale+OE | $25.03 | -16.8K | 187.2K | -8% | -$421.5K |
| DMT | 2026-08-12 16:48 | 2026-08-10+ | OMDA | Cook Steven L. | CFO | M - OptEx | $0.00 | -16.8K | 234.6K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-10 | M | A | 13,499 | $8.28 | 200,708 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. |
| 2 | Common | Common Stock | 2026-08-10 | M | A | 1,042 | $8.01 | 201,750 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. |
| 3 | Common | Common Stock | 2026-08-10 | M | A | 694 | $7.68 | 202,444 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. |
| 4 | Common | Common Stock | 2026-08-10 | S | D | 15,235 | $25.03 | 187,209 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. (F2) This transaction was executed in multiple trades at prices ranging from $25.00 to $25.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-08-11 | M | A | 1,607 | $8.28 | 188,816 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. |
| 6 | Common | Common Stock | 2026-08-11 | S | D | 1,607 | $25.01 | 187,209 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. (F3) This transaction was executed in multiple trades at prices ranging from $25.00 to $25.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-08-10 | M | D | 13,499 | $0.00 | 236,196 | D | $8.28 · — to 2031-07-19 | 13,499 Common Stock | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. (F4) 100% of the shares subject to the option are fully vested and exercisable. |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-08-10 | M | D | 1,042 | $0.00 | 18,750 | D | $8.01 · — to 2034-02-08 | 1,042 Common Stock | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. (F5) 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 9 | Derivative | Stock Option (Right to Buy) | 2026-08-10 | M | D | 694 | $0.00 | 20,834 | D | $7.68 · — to 2035-01-27 | 694 Common Stock | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. (F6) 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 10 | Derivative | Stock Option (Right to Buy) | 2026-08-11 | M | D | 1,607 | $0.00 | 234,589 | D | $8.28 · — to 2031-07-19 | 1,607 Common Stock | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. (F4) 100% of the shares subject to the option are fully vested and exercisable. |